Market Overview

The Medicines Company, Alnylam Announce Global Alliance

Related MDCO
Coronado Falls on TSO Study Results - Analyst Blog
Hyperion's Ravicti Submission Accepted in EU - Analyst Blog

The
Medicines Company (NASDAQ: MDCO) and Alnylam
Pharmaceuticals (NASDAQ: ALNY) announced today that they have formed
an exclusive global alliance for the development and commercialization
of Alnylam's ALN-PCS RNAi therapeutic program for the treatment of
hypercholesterolemia.

“This new alliance unites two organizations with a shared culture and
commitment to innovation. In my view and past experience, there could be
no stronger partner for our ALN-PCS program than The Medicines Company,
which has demonstrated industry-wide leadership in the advancement of
cardiovascular medicines to patients and remarkable success in its
strategy of in-licensing, developing, and commercializing breakthrough

See full press release

Posted-In: Earnings News Guidance Contracts Management

 

Most Popular

Related Articles (ALNY + MDCO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free